Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Gland Pharma Ltd

Gland Pharma Ltd share price and stock overview

Gland Pharma Ltd (NSE: GLAND, BSE: 543245) operates in the Pharmaceuticals - Indian - Formulations sector. The stock has an ISIN of INE068V01023 and a face value of Rs 1. As of 12 August 2026, it trades at Rs (2,924.40) with a market capitalisation of Rs 43938.87 crore. Figures are live and subject to change.

Gland Pharma Ltd

Pharmaceuticals - Indian - Formulations
NSE BSE
2,924.40 257.10 (9.64%) upARrowC
As on: 12-Aug-2026 , 01:43 AM
Market Cap(₹Cr) 43938.87
Book Value(₹Cr) 655.2871714
BSE Code : 543245 NSE Symbol : GLAND EPS(TTM) : 79.73 ISIN Demat : INE068V01023 P/E(TTM) : 33.41 Face Value(₹) : 1 Div & Yield % : 0.75

Today Market

Stock Performance

Today Market

Today's High

78,509.77

Todday's Low

78,048.26

Open at

78,509.77

Previous Close

78,542.44

Volumes

Avg Price

-388.19

Historical Performance

News

10 Aug 26
Gland Pharma Ltd consolidated sales up 3.30% on year in Q2FY2026
Gland Pharma Ltd share price slipped 0.65% to Rs 2600.45 after the company's net profit contracted by 13.
05 Aug 26
Gland Pharma to build sterile manufacturing suite at Visakhapatnam facility for Neuland
Gland Pharma Limited and Neuland Laboratories Limited announced a long-term strategic contract development and manufacturing organization (CDMO) partnership, under which Gland Pharma will establish a sterile manufacturing suite at its JNPC facility in Visakhapatnam to support Neuland’s demand for sterile APIs, with the suite designed to add approximately 1400 kg of annual capacity.
31 Jul 26
Audit of company’s BRSR reveals ESG performance indicators across multiple sites
An independent audit verified a company’s Business Responsibility and Sustainability Report (BRSR), revealing key environmental, social, and governance (ESG) performance indicators.
30 Jul 26
Gland Pharma Limited granted 6,979 equity shares to employees via stock options
Gland Pharma Limited announced that its ESOP Compensation Committee has allotted 6,979 equity shares of Re.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
11-08-26 2845.50 2988.40 2808.00 2924.40 8760097 485597 25380240103.90 24471.70
10-08-26 2632.00 2685.00 2610.10 2667.30 720772 44306 1916664133.70 24583.80
07-08-26 2601.00 2619.90 2570.00 2601.00 317731 27434 824387694.30 24570.65
06-08-26 2570.00 2626.40 2557.00 2608.30 503618 41831 1309962802.50 24636.00
05-08-26 2587.50 2595.70 2531.10 2545.10 299935 36112 765900567.40 24624.65
04-08-26 2579.20 2634.30 2561.10 2583.10 765513 55429 1995777232.70 24614.90
03-08-26 2505.60 2585.00 2494.10 2579.20 502554 33396 1286519330.40 24774.30
31-07-26 2525.30 2535.90 2500.00 2502.90 266828 39121 671617236.00 24383.60
30-07-26 2565.00 2586.00 2493.00 2517.00 745911 69200 1889131856.20 24317.15
29-07-26 2428.70 2550.00 2428.70 2543.70 841656 48037 2103972050.80 24250.20
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

43938.87

PE Ratio

33.41

PB Ratio

4.06

Dividend Yield

0.75

ROE

12.64

ROCE

17.11

Book Value (₹)

655.2871714

Face Value (₹)

1

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 85393934 51.77 85393934 5
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 85393934 51.77 85393934 5
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group 85393934 51.77 85393934 5
plus   Publice Share Holding
plus  Institution
Government(Central / State) 760 0.00 760 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 102 0.00 102 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 14417504 8.74 14417504 218
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2106522 1.28 2106522 6
Mutual Funds / UTI 46573490 28.23 46573490 27
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1538275 0.93 1538275 32
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 64636653 39.18 64636653 286
plus  Non Institution
Bodies Corporate 8273866 5.02 2273866 689
Clearing Members 38794 0.02 38794 33
Directors & their Relatives 77887 0.05 77887 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 397079 0.24 397079 2568
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 179223 0.11 179223 1889
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1000000 0.61 1000000 1
Individuals holding nominal share capital up to Rs. 1 lakh 4772804 2.89 4772804 102675
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 60080 0.04 60080 4
Others 27026 0.02 27026 1
Sub Total 14929095 9.05 8929095 107975
Total Public Shareholding 79565748 48.23 73565748 108261
Total of Promoter & Public ShareHolding 164959682 100.00 158959682 108266
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 164959682 100.00 158959682 108266

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales6,430.655,616.505,664.723,624.604,400.71
OPM (%)23.1518.9219.9930.6536.78
OP1,488.931,062.661,132.541,111.041,618.55
Other Income316.33213.61170.24240.46223.94
PBIDT1,921.531,482.531,503.311,208.771,734.09
INTEREST33.2842.0026.207.455.24
PBDT1,888.251,440.531,477.111,201.321,728.85
PBT1,440.231,062.661,132.54998.121,618.55
EO-24.350.000.00-56.460.00
PBT after EO1,464.581,062.661,132.541,054.581,618.55
TAXES437.26364.13360.08273.54406.89
PAT1,027.32698.53772.46781.041,211.66
EPS62.2842.4046.8947.4373.64
Raw Material34.8335.1235.7047.3646.51
Power and Fuel3.153.554.063.442.16
Employee Cost25.3324.9522.1911.137.69
Other Manufacturing Expenses1.671.651.521.570.93
Selling and Administration Expenses4.634.765.065.184.10
Miscellaneous Expenses1.201.341.581.230.80
Revenue (Growth %) 14.50-0.8556.29-17.6427.08
PBIDT (Growth %)29.61-1.3824.37-30.2920.67
PAT (Growth %) 47.07-9.57-1.10-35.5421.54
PBIDT (Margin %)29.8826.4026.5433.3539.40
PAT (Margin %) 15.9812.4413.6421.5527.53

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 16.4816.4816.4716.4716.4316.36
Reserves Total 10793.569738.638978.827936.837141.725886.93
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.080.00
Total Shareholders Funds10810.049755.118995.297953.307158.235903.29
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 2.755.233.664.454.745.00
Total Debt2.755.233.664.454.745.00
Other Liabilities46.9122.8420.691.731.731.73
Total Liabilities10859.709783.189019.647959.487164.705910.02
APPLICATION OF FUNDS :
Gross Block 2914.692798.042579.912294.962081.321430.70
Less : Accumulated Depreciation 1226.261053.05886.18724.41579.13476.47
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 1688.431744.991693.731570.551502.19954.23
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress137.6342.21120.01177.22190.75337.81
Producing Properties0.000.000.000.000.000.00
Investments 3292.552789.572385.748.16163.030.55
Current Assets, Loans & Advances
Inventories 1265.201254.231260.211945.301185.671275.17
Sundry Debtors 1520.691142.901171.40862.841074.81670.97
Cash and Bank Balance3177.642432.621598.553767.003085.803005.20
Loans and Advances 458.69937.21541.17313.20343.30171.73
Total Current Assets6422.215766.964571.326888.345689.575123.07
Less : Current Liabilities and Provisions
Current Liabilities 569.95472.18381.12698.17538.93458.34
Provisions 62.8349.8732.0731.3242.7553.82
Total Current Liabilities & Provisions632.77522.05413.19729.49581.68512.16
Net Current Assets5789.445244.914158.146158.855107.894610.90
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets15.738.988.2822.717.656.02
Deferred Tax Liability130.48125.38116.54106.9295.4179.90
Net Deferred Tax-114.75-116.40-108.26-84.21-87.76-73.88
Other Assets66.3977.89770.30128.92288.6080.40
Total Assets10859.699783.169019.657959.487164.705910.01
Contingent Liabilities10.1221.3815.5822.0712.7674.70

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities 34.9014.92-7.40-339.54-316.18
Investing Activities -1,006.921,211.22-2,917.581,582.29-74.03
Net Cash Flow -180.731,594.04-1,789.012,316.42745.02
Operating Activities 791.29367.891,135.971,073.671,135.23

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
SS
SRINIVAS SADU
Chairman / Executive Director / MD / CEO
Executive
Functional Directors
WRK
William Robert Keller
Additional Director
Dir.
Independent Directors
UJV
UDO JAHANNES VETTER
Independent Non Exe. Director
Ind.
EGV
ESSAJI GOOLAM VAHANVATI
Independent Non Exe. Director
Ind.
JA(
Jia Ai (Allen) Zhang
Non-Exec & Non-Independent Dir
Ind.
NLK
Naina Lal Kidwai
Independent Non Exe. Director
Ind.
WZ
Wenjie Zhang
Non-Exec & Non-Independent Dir
Ind.
WH
Wei Huang
Non-Exec & Non-Independent Dir
Ind.
Company Secretary & Compliance
SKP
SAMPATH KUMAR PALLERLAMUDI
CS / Compliance Officer / Vice President
Sec.

Frequently Asked Questions

What is the NSE symbol and BSE code for Gland Pharma Ltd? −

Gland Pharma Ltd trades on NSE under GLAND and on BSE under code 543245. The ISIN is INE068V01023 and the face value is Rs 1.

What is the share price of Gland Pharma Ltd today? +

As of 12 August 2026, Gland Pharma Ltd trades at Rs 2,924.40, a change of 257.10 (9.64%) on the day. Prices are live and subject to change.

What is the market capitalisation of Gland Pharma Ltd? +

As of 12 August 2026, Gland Pharma Ltd has a market cap of about Rs 43938.87 crore. This figure is live and moves with the share price.

Is Gland Pharma Ltd profitable? +

In March 2026, Gland Pharma Ltd reported a profit after tax of Rs 1,027.32 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Gland Pharma Ltd? +

: As of 12 August 2026, the PE (TTM) for Gland Pharma Ltd is 33.41 and the price-to-book ratio is 4.06. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Gland Pharma Ltd pay a dividend? +

As of 12 August 2026, the dividend yield for Gland Pharma Ltd is 0.75%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Gland Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 51.77% of Gland Pharma Ltd. Public shareholding is 48.23%, including mutual funds at 28.23% and foreign institutional investors at 8.74%.

What were the latest annual financials of Gland Pharma Ltd? +

In March 2026, Gland Pharma Ltd reported net sales of Rs 6,430.65 crore, revenue growth of 14.50%, and earnings per share of Rs 62.28.
We are hiring! Check out open positions and send your CV to csecrecruit@chola.murugappa.com
View Careers
Pre-Apply for IPOs
Chola Securities App
Install
🌐
Stay on Web